Literature DB >> 19748896

Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins.

Erinna F Lee1, Anna Fedorova, Kerry Zobel, Michelle J Boyle, Hong Yang, Matthew A Perugini, Peter M Colman, David C S Huang, Kurt Deshayes, W Douglas Fairlie.   

Abstract

Interactions between Bcl-2 homology-3 (BH3)-only proteins and their pro-survival Bcl-2 family binding partners initiate the intrinsic apoptosis pathway. These interactions are mediated by a short helical motif, the BH3 domain, on the BH3-only protein, which inserts into a hydrophobic groove on the pro-survival molecule. To identify novel peptidic ligands that bind Mcl-1, a pro-survival protein relative of Bcl-2, both human and mouse Mcl-1 were screened against large randomized phage-displayed peptide libraries. We identified a number of 16-mer peptides with sub-micromolar affinity that were highly selective for Mcl-1, as well as being somewhat selective for the species of Mcl-1 (human or mouse) against which the library was panned. Interestingly, these sequences all strongly resembled natural BH3 domain sequences. By switching residues within the best of the human Mcl-1-binding sequences, or extending beyond the core sequence identified, we were able to alter the pro-survival protein interaction profile of this peptide such that it now bound all members tightly and was a potent killer when introduced into cells. Introduction of an amide lock constraint within this sequence also increased its helicity and binding to pro-survival proteins. These data provide new insights into the determinants of BH3 domain:pro-survival protein affinity and selectivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748896      PMCID: PMC2781529          DOI: 10.1074/jbc.M109.048009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis.

Authors:  Felix F Vajdos; Camellia W Adams; Timothy N Breece; Leonard G Presta; Abraham M de Vos; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

3.  Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes.

Authors:  L Van Parijs; Y Refaeli; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

4.  Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid.

Authors:  M A Perugini; P Schuck; G J Howlett
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

5.  Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1.

Authors:  N J Skelton; Y M Chen; N Dubree; C Quan; D Y Jackson; A Cochran; K Zobel; K Deshayes; M Baca; M T Pisabarro; H B Lowman
Journal:  Biochemistry       Date:  2001-07-24       Impact factor: 3.162

6.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function.

Authors:  Xinqi Liu; Shaodong Dai; Yanan Zhu; Philippa Marrack; John W Kappler
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

7.  The functional binding epitope of a high affinity variant of human growth hormone mapped by shotgun alanine-scanning mutagenesis: insights into the mechanisms responsible for improved affinity.

Authors:  Gabor Pal; Anthony A Kossiakoff; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2003-09-05       Impact factor: 5.469

8.  A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).

Authors:  W Douglas Fairlie; Alessandro D Uboldi; George J Hemmings; Brian J Smith; Helene M Martin; Phillip O Morgan; Manuel Baca
Journal:  Biochemistry       Date:  2003-11-18       Impact factor: 3.162

9.  Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.

Authors:  W Douglas Fairlie; Alessandro D Uboldi; Joanne E McCoubrie; Chunxiao C Wang; Erinna F Lee; Shenggen Yao; David P De Souza; Sandra Mifsud; Donald Metcalf; Nicos A Nicola; Raymond S Norton; Manuel Baca
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

10.  Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members.

Authors:  Tristan Gallenne; Fabien Gautier; Lisa Oliver; Eric Hervouet; Belinda Noël; John A Hickman; Olivier Geneste; Pierre-François Cartron; François M Vallette; Stephen Manon; Philippe Juin
Journal:  J Cell Biol       Date:  2009-04-20       Impact factor: 10.539

View more
  17 in total

1.  Identification of a novel Mcl-1 protein binding motif.

Authors:  William J Placzek; Mattia Sturlese; Bainan Wu; Jason F Cellitti; Jun Wei; Maurizio Pellecchia
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

2.  Mutation to Bax beyond the BH3 domain disrupts interactions with pro-survival proteins and promotes apoptosis.

Authors:  Peter E Czabotar; Erinna F Lee; Geoff V Thompson; Ahmad Z Wardak; W Douglas Fairlie; Peter M Colman
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

Review 3.  Protein binding specificity versus promiscuity.

Authors:  Gideon Schreiber; Amy E Keating
Journal:  Curr Opin Struct Biol       Date:  2010-11-09       Impact factor: 6.809

4.  BH3-triggered structural reorganization drives the activation of proapoptotic BAX.

Authors:  Evripidis Gavathiotis; Denis E Reyna; Marguerite L Davis; Gregory H Bird; Loren D Walensky
Journal:  Mol Cell       Date:  2010-11-12       Impact factor: 17.970

5.  Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.

Authors:  Delphine Mérino; Seong L Khaw; Stefan P Glaser; Daniel J Anderson; Lisa D Belmont; Chihunt Wong; Peng Yue; Mikara Robati; Belinda Phipson; Walter D Fairlie; Erinna F Lee; Kirsteen J Campbell; Cassandra J Vandenberg; Suzanne Cory; Andrew W Roberts; Mary J C Ludlam; David C S Huang; Philippe Bouillet
Journal:  Blood       Date:  2012-04-26       Impact factor: 22.113

6.  Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes.

Authors:  Erinna F Lee; Oliver B Clarke; Marco Evangelista; Zhiping Feng; Terence P Speed; Elissaveta B Tchoubrieva; Andreas Strasser; Bernd H Kalinna; Peter M Colman; W Douglas Fairlie
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

7.  Locating Herpesvirus Bcl-2 Homologs in the Specificity Landscape of Anti-Apoptotic Bcl-2 Proteins.

Authors:  Glenna Wink Foight; Amy E Keating
Journal:  J Mol Biol       Date:  2015-05-23       Impact factor: 5.469

8.  Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL.

Authors:  Sanjib Dutta; Stefano Gullá; T Scott Chen; Emiko Fire; Robert A Grant; Amy E Keating
Journal:  J Mol Biol       Date:  2010-04-02       Impact factor: 5.469

9.  Iterative optimization yields Mcl-1-targeting stapled peptides with selective cytotoxicity to Mcl-1-dependent cancer cells.

Authors:  Raheleh Rezaei Araghi; Gregory H Bird; Jeremy A Ryan; Justin M Jenson; Marina Godes; Jonathan R Pritz; Robert A Grant; Anthony Letai; Loren D Walensky; Amy E Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

Review 10.  Intrinsically disordered proteins in bcl-2 regulated apoptosis.

Authors:  Gilles J P Rautureau; Catherine L Day; Mark G Hinds
Journal:  Int J Mol Sci       Date:  2010-04-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.